NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Marico Ltd Sets Ambitious Revenue Targets for FY27 and FY30

Mumbai: Marico Ltd, a leading consumer goods company behind popular brands such as Parachute and Saffola, has set its sights on achieving significant revenue milestones in the coming years. The company aims to earn ₹15,000 crore in revenue by the end of FY27 and ₹20,000 crore by FY30.

To meet its ambitious targets, Marico Ltd is shifting its focus towards premium products, packaged foods, and a digital-first approach. The company plans to tap into the growing wellness and premium personal care segments, a move away from its traditional commodity-centric profile. By leveraging these new areas of focus, Marico Ltd is well-positioned to drive growth and expand its market presence in the coming years.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should focus on Marico's premium products and digital-first push for long-term growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.